|
|
||||||||
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115, USA
(RECEIVED April 27, 2007; FINAL REVISION June 13, 2007; ACCEPTED June 13, 2007)
| Abstract |
|---|
|
|
|---|
Keywords: phospholamban pentamer; pseudophosphorylation; NMR
| Introduction |
|---|
|
|
|---|
helical membrane protein (52 amino acids) that assembles spontaneously into a 30 kDa pentamer in the SR membrane of heart muscle cells (MacLennan and Kranias 2003). It is the main, but not the only regulator of SERCA. In the unphosphorylated form, PLN has an inhibitory effect on the calcium pump, thereby decreasing the magnitude of calcium cycling and muscle contractility. Heart stimulants, such as adrenaline, set off a chain of signal transduction events that among other effects lead to PLN phosphorylation. Phosphorylated PLN no longer inhibits SERCA, allowing for larger muscle contractility.
Substantial progress has been made toward an understanding of this phosphorylation-dependent regulatory mechanism at the atomic resolution. The crystal structure of SERCA is available (Toyoshima and Nomura 2002), and its putative sites of interaction with PLN have been proposed based on a number of chemical cross-linking and mutagenesis experiments (Toyoshima et al. 2003). The solution structures of both the monomeric mutants (Lamberth et al. 2000; Zamoon et al. 2003) and the pentameric wild type (Oxenoid and Chou 2005) of PLN have been determined by NMR spectroscopy. In addition, a recent study reported two-dimensional co-crystallization of the I40A PLN mutant, believed to be monomeric based on SDS-PAGE experiments, and SERCA (Stokes et al. 2006). Although the two-dimensional crystal diffracts poorly to
17 Å, a low-resolution projection map could be reconstructed. The map unexpectedly reveals PLN densities that are more consistent with the oligomeric form than the monomer, suggesting that SERCA can directly interact with the native pentameric assembly of PLN. Despite this progress, there has not been a high-resolution structure reported of a PLN–SERCA complex from which a definitive mechanism of phosphorylation-dependent regulation can be deduced.
A controversial yet important question concerning PLN structure is whether phosphorylation has an effect on the conformation and how potential structural changes relate to the interaction between PLN and SERCA. Limited proteolysis experiments showed a reduction in the sensitivity of PLN to digestion by proteases after phosphorylating Ser16, suggesting that the PLN pentamer structure becomes more stable upon phosphorylation (Huggins and England 1987). However, more direct measurements using circular dichroism (CD) and Fourier transform infrared (FTIR) methods did not observe any significant changes in the secondary structure of PLN upon phosphorylation (Simmerman et al. 1989; Arkin et al. 1995). Solution NMR studies on the AFA-PLN monomeric mutant (with C36A, C41F, C46A mutations) showed that the helical region near Ser16 (residues 14–21) becomes disordered upon phosphorylation (Metcalfe et al. 2005), whereas a recent solid-state NMR study of the wild-type (WT) PLN in lipid bilayer reported that Ala15 of the extramembrane domain near the phosphorylation site is a part of an
helical structure for both unphosphorylated and phosphorylated PLN (Abu-Baker and Lorigan 2006).
To provide further details of potential structural perturbation of PLN caused by phosphorylation, we compare the structure and dynamics of the WT PLN with its phosphorylation-mimicking mutant that has a S16E substitution. Mutations of serine and threonine to aspartic or glutamic acids are often used to study the effects of protein phosphorylation (Park et al. 2006; Yang et al. 2007). Using adenoviral vector delivery, it has been shown in the mouse model that expression of the S16E mutant causes an increase in muscle contraction and relaxation. Moreover, this effect was no longer dependent on
-adrenergic agonists, mimicking constitutively phosphorylated PLN (Hoshijima et al. 2002). A practical advantage of choosing the S16E mutation over phosphorylation by kinase is to avoid the difficulty of achieving 100% phosphorylation as well as problems of dephosphorylation in the NMR sample over an extended period of time. Extensive NMR measurements including NOEs, residual dipolar couplings (RDCs), and amide-solvent exchange factors indicate that the structure of the S16E mutant is almost identical to that of the WT. R1 and R2 relaxation rates and heteronuclear NOEs, however, suggest subtle differences in the chemical exchange and dynamics in the extramembrane domain (residues 1–20) that may have implications in the reduced inhibitory activity of PLN upon phosphorylation.
| Results and Discussion |
|---|
|
|
|---|
helix (residues 2–15), a partially structured and extended linker (residues 16–22), and a transmembrane (TM) coiled-coil domain that holds the pentamer together (Oxenoid and Chou 2005). The phosphorylation sites Ser16 and Thr17 are near the C-terminal end of the extramembrane helix. An intriguing question is whether introducing negative charges at Ser16 and/or Thr17 perturbs the structure of the pentameric assembly.
The 1H-15N TROSY spectra of the WT and the S16E mutant PLN pentamers are compared in Figure 1A. The residue-specific chemical-shift changes are quantified by the chemical-shift distance (
, normalized to 1H chemical shift) between perturbed resonances, defined as
where
is the ratio of total resonance dispersion of 15N to that of 1H in ppm, and
H and
N are 1H and 15N chemical-shift changes in ppm, respectively (Fig. 1B). In the case of PLN, pentamer reconstituted in DPC micelles,
= 10. The resonances corresponding to the membrane-embedded region (residues 23–52) essentially do not change, indicating that the structure of the coiled-coil assembly is not at all affected by the S16E mutation. However, there are chemical-shift perturbations in regions close to the phosphorylation site, with the largest change in residues 13–17, and smaller but significant changes in residues 8–12 and 18–20. The long-range chemical-shift perturbation may be a result of alteration of either structure or dynamics, or both.
|
helix. The structure of the nonhelical region (residues 16–22) connecting the extramembrane
helix and the TM domain is also very similar to that of the WT. In addition, 1H-15N RDCs were measured for the S16E mutant marginally oriented in a stretched polyacrylamide gel and are compared with those previously measured for the WT protein weakly oriented in the same medium. The RDCs from the two proteins agree very well, with a correlation coefficient of 0.94 (Fig. 2B). Note in Figure 2B that the linear regression line crosses the (0,0) point (considering an error margin of
0.4 Hz in RDC measurement), indicating that the structures and the alignment tensors of the WT and the mutant are almost identical.
|
and/or
protons, 15N-, 2H-labeled proteins were used along with deuterated detergent. The ratios of peak intensity in the attenuated spectrum (Isat) to that in the reference spectrum (Iref) are shown in Figure 2C. There are essentially no differences in residue-specific Isat/Iref between the WT and the mutant in DPC micelles except for residues 15–17. For these three residues, the differences in attenuation are probably due to NOE from presaturating the OH group of Ser16 in the WT, which is absent in the mutant. The similarity in amide–water exchange factors suggests that the mutation does not affect the local secondary structures, nor does it alter the way the pentamer is assembled in the detergent micelles. The results of a combined analysis of chemical-shift perturbation, NOEs, RDCs, and amide–water exchange allow us to conclude that there are no detectable differences in both secondary and tertiary structures between the WT and the S16E mutant. Since the S16E mutation is recognized as a pseudophosphorylation mutation (Hoshijima et al. 2002), the above results indicate that the structure of the PLN pentamer is not significantly perturbed upon phosphorylation of Ser16.
The S16E mutation causes subtle changes in the protein dynamics
Structural similarity does not necessarily translate into similarity in protein dynamics. The dynamic properties of the S16E mutant and the WT PLN were compared by performing standard relaxation experiments for the two proteins under identical sample and spectrometer conditions. Residue-specific 15N R1 and R2 relaxation rates and 1H-15N NOEs were obtained at 30°C using the standard pulse schemes described previously in Kay et al. (1989).
Figure 3A shows that the R2 /R1 ratios, which probe for global motion on the nanosecond timescale (Kay et al. 1989), are very similar in the WT and the mutant. In both cases, the TM domain has larger R2 /R1 ratios than the extramembrane helix, suggesting that the mobility of the extramembrane helix relative to the TM domain is present in both unphosphorylated and phosphorylated PLN. However, the R2R1 products, which probe for variations in the slower microsecond–millisecond chemical-exchange process (Kneller et al. 2002), reveal significant differences between the WT and the mutant at the positions of Thr8 and Thr17 (Fig. 3B). In the WT, there is larger-than-average chemical exchange associated with 15N of Thr8 that is consistent with the corresponding weak and broad resonance in the TROSY spectrum (see Fig. 1A). This unusually large chemical exchange is no longer present in the S16E mutant. On the other hand, Thr17 15N has average chemical exchange in the WT, but larger-than-average chemical exchange in the mutant. The R2R1 products corresponding to the TM domain are essentially the same for the WT and the mutant. Finally, to examine whether the S16E mutation changes the internal dynamics of the pentamer, the 15N(1H) heteronuclear NOEs, which are much more sensitive to fast internal dynamics than R1 and R2 , have been measured. Figure 3C shows that the NOEs measured for the WT and the mutant are also very similar. The average NOE value for the WT (0.68 ± 0.04) is slightly lower than that of the mutant (0.73 ± 0.04), suggesting that phosphorylation may have further stabilized the pentameric assembly.
|
Conclusions
The structure of the PLN pentamer is not changed by the S16E phosphorylation-mimicking mutation in DPC micelles. Since replacing Ser16 with the acidic glutamate has been demonstrated to have the same effect as phosphorylation, the above result suggests that phosphorylation does not change the conformation of the pentameric assembly. The lack of differences is consistent with the above-mentioned spectroscopic studies of the effect of phosphorylation on the WT PLN pentamer (Simmerman et al. 1989; Arkin et al. 1995; Abu-Baker and Lorigan 2006). However, this result is seemingly contradictory to the report that phosphorylation of the AFA monomeric mutant causes a significant portion of the extramembrane domain (residues 14–21) to become disordered (Metcalfe et al. 2005). A plausible explanation is that the conformational stability of PLN in the pentameric form is higher than that of the monomeric AFA–PLN because helix–helix packing stabilizes the secondary structure. According to the PLN pentamer structure in DPC micelles, although the extramembrane helices point out of the membrane into the solution, they are supported by a partially structured linker, unlike the monomeric AFA–PLN. Moreover, these helices in the pentamer can weakly interact with and support each other when taking into account their water hydration radius. Thus, the physical properties of the PLN pentamer are fundamentally different from those of the monomer.
There are some subtle differences in the dynamic properties between the mutant and the WT. These differences reside mostly in the extramembrane region of PLN encompassing the amphipathic helix and the nonhelical segment connecting the amphipathic and the TM helices. Since the extramembrane region of PLN is known to be more dynamic and important for interaction with SERCA, the subtle changes in dynamics upon phosphorylation could play a role in altering interaction with SERCA. Alternatively, it may simply be that the addition of negative charges modulates electrostatic ineractions in the PLN–SERCA complex. A high-resolution structure of such a complex will be invaluable for addressing the mechanism of SERCA regulation by PLN.
| Materials and Methods |
|---|
|
|
|---|
Sample preparation
The genes encoding WT human PLN and the S16E mutant were cloned into the pMALc2x vector (New England Biolabs) and expressed as a maltose-binding protein (MBP) fusion protein. The detailed procedures of protein expression, purification, and reconstitution in detergent micelles are as described in Oxenoid and Chou (2005).
NMR
The sequence-specific assignment of backbone 1H and 15N resonances of the S16E mutant was accomplished using the 3D HNCA and 15N-separated NOESY spectra acquired on 15N-, 13C-labeled protein, and the known assignments of the WT PLN (Oxenoid and Chou 2005). Intramonomer NOEs were assigned using the 3D 15N-separated NOESY spectra recorded with NOE mixing time of 120 ms.
For RDC measurements for the S16E mutant, weak alignment of the protein–detergent complex was accomplished using a modified version (Chou et al. 2001) of the strain-induced alignment in a gel (SAG) method (Sass et al. 2000; Tckyo et al. 2000). The 15N-labeled protein in DPC micelles was soaked into a cylindrically shaped polyacrylamide gel (4% acrylamide concentration and acrylamide/bisacrylamide molar ratio of 80), initially of 6 mm diameter and 9 mm length, which was subsequently radially compressed to fit within the 4.2 mm inner diameter of a NMR tube with open ends (http://newera-spectro.com), thereby increasing its length to 18 mm. The RDCs were obtained by subtracting J of the unaligned sample from J + D of the aligned sample. The sign of dipolar couplings follows the convention that |1 J NH + 1 D NH| <90 Hz when 1 D NH is positive. The 1H-15N RDCs were obtained from 1 J NH/2 and (1 J NH + 1 D NH)/2, which were measured at 600 MHz (1H frequency) by interleaving a regular gradient-enhanced HSQC and a gradient-selected TROSY, both acquired with 80 ms of 15N evolution.
The relative amide protection from water was measured by recording two interleaved 1H-15N TROSY spectra, one in the absence and the other in the presence of 1 sec of presaturation of the water resonance. The samples used for this experiment were 15N-, 2H-labeled WT, and S16E PLN reconstituted in deuterated DPC. The same samples were used for measurements of 15N R1 , R2 , and 15N(1H) NOE using the standard pulse schemes described in Kay et al. (1989).
All NMR data were collected at 30°C on Bruker spectrometers operating at 1H frequencies of 600 MHz and equipped with cryogenic probes. Data processing and spectra analyses were done in NMRPipe (Delaglio et al. 1995) and XEASY (Bartels et al. 1995).
| Footnotes |
|---|
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.072975107.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Arkin, I.T., Rothman, M., Ludlam, C.F., Aimoto, S., Engelman, D.M., Rothschild, K.J., and Smith, S.O. 1995. Structural model of the phospholamban ion channel complex in phospholipid membranes. J. Mol. Biol. 248: 824–834.[CrossRef][Medline]
Bartels, C., Xia, T., Billeter, M., Güntert, P., and Wüthrich, K. 1995. The program XEASY for computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 6: 1–10.[Medline]
Chou, J.J., Gaemers, S., Howder, B., Louis, J.M., and Bax, A. 2001. A simple apparatus for generating stretched polyacrylamide gels, yielding uniform alignment of proteins and detergent micelles. J. Biomol. NMR 21: 377–382.[CrossRef][Medline]
Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. 1995. NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6: 277–293.[Medline]
Hoshijima, M., Ikeda, Y., Iwanaga, Y., Minamisawa, S., Date, M.O., Gu, Y., Iwatate, M., Li, M., Wang, L., Wilson, J.M., et al. 2002. Chronic suppression of heart-failure progression by a pseudophosphorylated mutant of phospholamban via in vivo cardiac rAAV gene delivery. Nat. Med. 8: 864–871.[Medline]
Huggins, J.P. and England, P.J. 1987. Evidence for a phosphorylation-induced conformational change in phospholamban from the effects of three proteases. FEBS Lett. 217: 32–36.[CrossRef][Medline]
Kay, L.E., Torchia, D.A., and Bax, A. 1989. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: Application to staphylococcal nuclease. Biochemistry 28: 8972–8979.[CrossRef][Medline]
Kneller, J.M., Lu, M., and Bracken, C. 2002. An effective method for the discrimination of motional anisotropy and chemical exchange. J. Am. Chem. Soc. 124: 1852–1853.[CrossRef][Medline]
Lamberth, S., Schmid, H., Muenchbach, M., Vorherr, T., Krebs, J., Carafoli, E., and Griesinger, C. 2000. NMR solution structure of phospholamban. Helv. Chim. Acta 83: 2141–2152.[CrossRef]
MacLennan, D.H. and Kranias, E.G. 2003. Calcium:Phospholamban: A crucial regulator of cardiac contractility. Nat. Rev. Mol. Cell Biol. 4: 566–577.[CrossRef][Medline]
Metcalfe, E.E., Traaseth, N.J., and Veglia, G. 2005. Serine 16 phosphorylation induces an order-to-disorder transition in monomeric phospholamban. Biochemistry 44: 4386–4396.[CrossRef][Medline]
Oxenoid, K. and Chou, J.J. 2005. The structure of phospholamban pentamer reveals a channel-like architecture in membranes. Proc. Natl. Acad. Sci. 102: 10870–10875.
Park, K.S., Mohapatra, D.P., Misonou, H., and Trimmer, J.S. 2006. Graded regulation of the Kv2.1 potassium channel by variable phosphorylation. Science 313: 976–979.
Sass, H.J., Musco, G., Stahl, S.J., Wingfield, P.T., and Grzesiek, S. 2000. Solution NMR of proteins within polyacrylamide gels: Diffusional properties and residual alignment by mechanical stress or embedding of oriented purple membranes. J. Biomol. NMR 18: 303–309.[CrossRef][Medline]
Simmerman, H.K., Lovelace, D.E., and Jones, L.R. 1989. Secondary structure of detergent-solubilized phospholamban, a phosphorylatable, oligomeric protein of cardiac sarcoplasmic reticulum. Biochim. Biophys. Acta 997: 322–329.[CrossRef][Medline]
Stokes, D.L., Pomfret, A.J., Rice, W.J., Glaves, J.P., and Young, H.S. 2006. Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals. Biophys. J. 90: 4213–4223.[CrossRef][Medline]
Tckyo, R., Blanco, F.J., and Ishii, Y. 2000. Alignment of biopolymers in strained gels: A new way to create detectable dipole-dipole couplings in high-resolution biomolecular NMR. J. Am. Chem. Soc. 122: 9340–9341.[CrossRef]
Toyoshima, C. and Nomura, H. 2002. Structural changes in the calcium pump accompanying the dissociation of calcium. Nature 418: 605–611.[CrossRef][Medline]
Toyoshima, C., Asahi, M., Sugita, Y., Khanna, R., Tsuda, T., and MacLennan, D.H. 2003. Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase. Proc. Natl. Acad. Sci. 100: 467–472.
Yang, Y., Craig, T.J., Chen, X., Ciufo, L.F., Takahashi, M., Morgan, A., and Gillis, K.D. 2007. Phosphomimetic mutation of Ser-187 of SNAP-25 increases both syntaxin binding and highly Ca2+-sensitive exocytosis. J. Gen. Physiol. 129: 233–244.
Zamoon, J., Mascioni, A., Thomas, D.D., and Veglia, G. 2003. NMR solution structure and topological orientation of monomeric phospholamban in dodecylphosphocholine micelles. Biophys. J. 85: 2589–2598.[Medline]
Zucchi, R. and Ronca-Testoni, S. 1997. The sarcoplasmic reticulum Ca2+ channel/ryanodine receptor: Modulation by endogenous effectors, drugs and disease states. Pharmacol. Rev. 49: 1–51.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Z. Hou, E. M. Kelly, and S. L. Robia Phosphomimetic Mutations Increase Phospholamban Oligomerization and Alter the Structure of Its Regulatory Complex J. Biol. Chem., October 24, 2008; 283(43): 28996 - 29003. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |